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Abstract
Background: No data on annual smoking cessation probability (i.e., the probability of successfully quit in a given
year) are available for Italy at a population level. Mathematical models typically used to estimate smoking cessation
probabilities do not account for smoking relapse. In this paper, we developed a mathematical model to estimate
annual quitting probabilities, taking into account smoking relapse and time since cessation.
Methods: We developed a dynamic model describing the evolution of current, former, and never smokers. We
estimated probabilities of smoking cessation by fitting the model with observed smoking prevalence in Italy, 1986-
2009.
Results: Annual cessation probabilities were higher than 5% only in elderly persons and in women aged < 30
years, while in adults aged 30-49 and 50-59 cessations were about 2% and 3-5%, respectively. Most of quit
probabilities stalled from 1986 to 2009.
Conclusions: Over the last 20 years, cessation probabilities among Italian smokers, particularly for those aged 30-59
years, have been very low and stalled. Quitting in Italy is considered as a practicable strategy only by women in
the age of pregnancy and by elderly persons, when it’s likely that symptoms of tobacco-related diseases have
already appeared. In order to increase cessation probabilities, smoking cessation treatment policies (introducing
total reimbursement of cessation treatments, with a further development of quitlines and smoking cessation
services) should be empowered and a country-wide mass media campaign targeting smokers aged 30-59 years
and focusing on promotion of quitting should be implemented.
Background
Smoking is a major risk factor for many tumours and
other chronic diseases, and responsible for the reduction
of length and quality of life [1]. In Italy, women smoking
prevalence declined from 19.2% in 1986 to 17.0% in
1993, and afterwards stalled at that level, while men
smoking prevalence declined from 41.6% in 1986 to
29.5% in 2009, with an average annual drop of 1.2% [2].
The reduction in smoking prevalence derived from the
joint effect of changes in smoking initiation and cessa-
tion. Data from multipurpose surveys carried out by the
Italian Institute of Statistics (ISTAT), showed a 15%
decrease in smoking initiation from 8.6% in 1994 to
7.3% in 2005, for girls aged 18-25 years, and a 28%
reduction, from 16.3% to 11.7%, for boys [2].
Cessation can be estimated using surveys on smoking
habits [3-6]. However, repeated and comparable surveys
on smoking habits over several decades are not always
available. Alternatively, cessation probability could be
estimated using data from representative cross-sectional
surveys through the use of mathematical models [7-9]
that are essentially based on a set of equations describ-
ing the demographic evolution by smoking habits,
depending on assumptions on the development of
smoking epidemic and on related parameters.
The knowledge of historical cessation trends (in addi-
tion to data on initiation and prevalence) is necessary to
characterize the dynamics of the tobacco epidemic [3].
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Previous models [7-9] estimated cessation probabilities
through an optimization procedure by selecting the
parameters that best reproduced the country-specific
observed prevalence figures. However, these models did
not take into account the smoking relapse, thus under-
estimating the real cessation probabilities. The success
of quit attempts, and therefore the relapse of smoking,
is an important aspect of smoking cessation.
In this paper, we develop a mathematical model to
describe the Italian observed smoking prevalence in the
years 1986-2009. Our aim is to estimate the annual ces-
sation probabilities for Italian smokers by taking into




We implemented a model of Italian smoking habits
(Figure 1), extending the work in [9]. In defining the
model, the population was stratified into three mutually
exclusive groups: current, never, and former smokers.
The latter group differs from the model in [9] for time
since smoking cessation. Current smokers were defined
as those who smoke ≥ 1 cigarette/day (i.e., both heavy
and light smokers), and former-smokers were defined as
those that currently do not smoke but have smoked in
the past [2].
We simulated the model in order to describe the
dynamics of the population over time, starting with the
number of current, never, and former smokers observed
in year 1986. The population’s evolution is described
through a demographic model that reports the annual
changes of the population numbers by gender and age,
taking into account births and deaths. The number of
newborns in each year was assumed to be the number of
children aged 0 observed in that calendar year. The pro-
posed model is based on a set of time-continuous differ-
ential equations, which describe the 1-year changes in
the prevalence of never, current, and former smokers,
specified by gender and age. The model was run for time
period 1986-2009, and for each year the model produced
age and sex-specific prevalences for current and former
smokers.
Data
Demographic data such as all cause mortality rates and
initial baseline population numbers were available from
the Italian Institute of Statistics (ISTAT). Smoking pre-
valence and initiation rate data by gender and age were
available from the ISTAT Multipurpose Surveys “Health
conditions and access to health services” and “Aspects
of daily living” [2]. These surveys were carried out
almost every year from 1986 to 2009 on representative
samples of the Italian population. Smoking prevalence
and initiation rate figures were linearly interpolated for
the missing years. Figures on the proportion of former
smokers by time since quitting were obtained from 10
surveys carried out annually in 2001-2010 by DOXA,
the Italian branch of the Gallup International Associa-
tion, on representative samples of the Italian population
aged ≥ 15 years [10]. Five categories of time since cessa-
tion were considered: 1-2 years, 3-5 years, 6-10 years,
11-15 years, and > 15 years. Mortality rates for current
and never smokers were derived from the Cancer Pre-
vention Study II [11].
Assumptions
Since data on smoking initiation rates show a fall after
24 years of age, we assumed that smoking initiation in
the model occurs between 18 and 24 years. Cessation
was tracked from age 25, since the relative risks of
death for smoking-related diseases are not discernable
for those who quit smoking before that age [11].
Relapse rates were assumed to follow a negative-expo-
nential curve depending on the time since quitting
[12,13]:
λrelapse(t) = αβ exp(−βt) (1)
The parameter b governs how fast the relapse rates
decline with time since smoking cessation, and the para-
meter a governs the lifetime probability of no relapse.
Under this assumption, the proportional decrease of
relapse rates is constant over time. Thus, the relapse
rates are highest shortly after cessation, and diminish in
the long run. Since data on relapse were not available for
Italy, we used the a and b parameters estimated from a
series of cross-sectional population surveys on smoking
behaviour for the Netherlands and we converted the
relapse rates in annual probabilities of relapse (condi-
tional on no relapse until that time) [12] (Figure 2).
We assumed that relative risks for former smokers
decrease according to a negative-exponential curve with
a convergence rate decreasing with age [12]. Relative
risks of former smokers are therefore allowed to
Figure 1 Model. Scheme of the model used to compute the
prevalence of smoking.
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gradually decrease over time since cessation being simi-
lar to those of current smokers immediately after cessa-
tion, and becoming similar to those of never smokers in
the long run. As for relapse rates, we parameterized the
negative-exponential curve according to estimates from
a series of cross-sectional population surveys on smok-
ing behaviour from the Netherlands [12]. We then con-
verted relative risks into death rates (Figure 3).
Estimation procedure
We estimated sex and age-specific annual cessation
probabilities for each year in three time periods (1986-
1992, 1993-1999, 2000-2009) by selecting the set of
parameters that best reproduced the age-specific
observed smoking prevalence [7-9]. The bounded
weighted least squares method was used as optimization
procedure [7-9]. The inverse variances of the observed
age-specific prevalence estimates were used as weights
to take into account the age-composition of the popula-
tion [7-9], and the parameters were constrained in the
interval [0,1] [9].
Intuitively, since the model output are smoking preva-
lences and the cessation probabilities are necessary
input parameters, the model was run several times with
a set of plausible values of cessation as input para-
meters. The values of cessation that let the model to
reproduce the prevalences closest to the observed ones
were then selected.
We used a probabilistic sensitivity analysis (PSA)
approach [14] to account for uncertainty of the smoking
prevalence data: prevalence of current, former, and never
smokers were assumed to jointly follow a probabilistic
distribution function. PSA was based on a simulation
approach: for each iteration, we randomly assigned a
value for the prevalence estimates of current, former, and
never smokers within its probabilistic distribution. We
then applied the optimization procedure and we esti-
mated a set of cessation probabilities for each iteration.
The resulting variability in the cessation probabilities was
then suitably summarized. We selected the Dirichlet dis-
tribution, generally used for several mutually exclusive
events, as the joint distribution function for prevalence
[8,9,14]. We parameterized the distribution by a vector of
positive real numbers that coded information on event
rates: the observed probabilities of being current, former
or never smokers were assumed as parameters. Note that
Dirichlet distribution parameters are related to the mean
and the variance of the event rates. Likewise, multiplying
such parameters by a scale factor, a Dirichlet distribution
with the same expected value and a different variability
could be obtained. In this application, we tuned the
observed prevalence by a scale factor to assure that the
resulting cessation probability estimates were normally
distributed, in order to easily estimate the mean and
build confidence intervals for the cessation probabilities.
Normality was tested with the Shapiro-Wilk test [15].
Results
Estimates of annual cessation probabilities and corre-
sponding confidence intervals are reported in Table 1.
The mean point estimates produced a good fit with an
R2 of 0.972 for women and 0.977 for men. Annual ces-
sation probabilities in both genders were higher in the
oldest age group: over the last period (2000-2009), prob-
abilities in women and men aged ≥ 60 years were 8.8%
and 8.5%, respectively (Table 1). Annual cessation prob-
abilities for women aged < 30 years were similar to
Figure 2 Relapse probability. Annual probabilities of relapse
(conditional on no relapse until that time) for females and males.
Figure 3 Death rates. Death rates for current smokers, never
smokers, and former smokers by time since quit smoking and
gender.
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those estimated for elderly women, around 8-10%, while
in young men cessation was around 5%. Cessation prob-
abilities in both women and men aged 30-49 years were
very low, around 2%, while in women and men aged 50-
59 years were around 3-5%.
Time trend of annual cessation probabilities in women
aged < 30 and 50-59 years showed a slight increase,
while in women aged 30-49 years stalled, and in women
aged ≥ 60 years showed a slight decrease. In men aged
< 50 years annual cessation probabilities slightly
decreased, while in men aged ≥ 50 years cessation prob-
abilities stalled.
For both young women and men (age < 30 years) ces-
sation probabilities resulted the more uncertain with
respect to the other age classes for the three periods.
On the contrary, estimates for both women and men
aged 30-39 years and ≥60 resulted the less uncertain
(Table 1).
Discussion
Estimates of annual cessation probabilities were higher
than 5% only in persons older than 60 years and in
women younger than 30 years, while in persons aged
30-59 years cessation estimates were around 2-5%. It’s
noteworthy that most of cessation probabilities stalled
from 1986 to 2009. Results may imply that quitting is
considered only by women in the age of pregnancy and
by elderly persons, when it’s likely that symptoms of
tobacco-related diseases have already appeared. Accord-
ingly, in Italy approximately half of former smokers
endorsed present health (i.e., current health conditions)
as the main reason they quit smoking [16].
The annual cessation probabilities estimated for
women aged 30-39 in the time period 1993-1999
resulted very low because most of cessation was cap-
tured in the previous age class (< 30 years). In fact,
younger women in 1993-1999 recorded higher cessation
probabilities in comparison to the other time periods.
In our model we assumed that smoking initiation
occurs between 18 and 24 years of age, even though it is
frequently reported that adolescent begin to smoke
before 18 years of age [17,18]. This assumption was
varied by considering smoking initiation at 14 years of
age, producing worst R2 values (0.523 and 0.496 for
women and men, respectively). Moreover, adolescent
smokers are often occasional smokers (triers, puffers,
experimenters), and they do not necessarily progress to
regular smoking [19].
Estimates of annual cessation probabilities from our
model were consistent with cessation probabilities
obtained with similar models for Italy [9], for USA [7]
and for Australia [8], and with survey estimates of cessa-
tion rates in the Spanish [3], Italian [4], English [5], and
US population [6].
Age-standardized quit rates were estimated for Italy
around 2-3% for males and 1-4% for females aged 20-44
years [4]. Cessation rates estimates for the English popu-
lation over 16 years of age were between 2% and 3% for
both genders in 2006 [5]. Similar analyses for Spain
reported the incidence of quitting smoking of 0-5% and
1-5% for males and females aged 20-50 years old, respec-
tively, and of 0-9% and 8-9% for males and females aged
> 50 years old, respectively [3]. Cessation rates in Califor-
nia increased by 25% from 1980s to the 1990s, averaging
3.4% per year in the 1990s. Cessation increased for all
age-groups, and by more than 40% among smokers aged
20-34 years [6]. Since in our model we estimated the
annual probability of smoking cessation independently
whether or not smokers successfully quitted after that
year, the resulting cessation estimates were slightly
higher than those reported in the other studies. The pre-
vious Italian model [9], as well as the other models and
survey estimates that does not take into account time
since quitting, accounted only for successful quitting (i.e.,
smoking abstinence for at least one year).
Empowering smoking cessation treatment policies and
launching media campaigns focusing on quitting promo-
tion among adults may increase quit attempts among Ita-
lian smokers, particularly those aged 31-59 years, whose
probabilities of making a quit attempt resulted very low.
Currently, the National Health System (NHS) does not
reimburse smokers for pharmacotherapy or behavioral
treatments [20,21], and these methods in 2011 were used
by 5% of former smokers [22]. Moreover, about 40% of
Table 1 Annual cessation probabilities estimates and corresponding 95% confidence interval by sex and time period.
Italy 1986-2009
Women Men
age group Time period
(years) 1986-1992 1993-1999 2000-2009 1986-1992 1993-1999 2000-2009
< 30 7.5 (6.4, 8.6) 10.1 (9.6, 10.6) 8.9 (7.9, 9.9) 6.2 (5.5, 6.9) 4.6 (3.7, 5.4) 4.8 (4.2, 5.3)
30-39 2.6 (1.8, 3.4) 0.0 (0.0, 0.0) 3.1 (2.5, 3.7) 2.5 (2.0, 2.9) 2.4 (1.9, 3.0) 1.9 (1.5, 2.2)
40-49 3.2 (2.4, 4.0) 1.1 (0.3, 1.8) 3.4 (2.8, 4.1) 3.1 (2.6, 3.6) 2.6 (1.9, 3.2) 2.1 (1.7, 2.5)
50-59 2.3 (1.3, 3.2) 6.2 (5.2, 7.3) 3.7 (3.2, 4.3) 3.5 (3.1, 4.0) 5.0 (4.4, 5.6) 4.1 (3.7, 4.5)
≥ 60 10.2 (10.0, 10.4) 8.5 (7.7, 9.4) 8.5 (7.8, 9.2) 8.4 (8.0, 8.7) 10.2 (10.2, 10.2) 8.8 (8.4, 9.3)
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smokers reported having received advice to quit by their
general practitioners [22,23], and each of the almost 300
NHS Smoking Cessation Services treated an average of
70-77 smokers only each year [24]. Finally, the two Italian
quitlines annually received about 7-8,000 calls, thus
reaching about 0.06-0.07% only of Italian smokers
[25,26]. Anti-tobacco media campaigns have been imple-
mented in Italy in 2002-2005 annually, in 2009, and 2010
[27] and their targets were young people to prevent
smoking initiation. The MPOWER Report [28] indicates
health expenditures of less than US$1 per person in Italy
for media campaign.
Limitations and strengths
Our model has some limitations due to simplifying
assumptions or to lack of data. Migration was not taken
into account because of the inadequate data on smoking
prevalence among migrants. However, since the resident
population is large with respect to immigrants, it is unli-
kely that the difference would significantly influence
results although smoking prevalence among immigrants
may differ from that in the resident population [10].
Despite the dependence of smoking-related mortality
on many factors, as the duration of smoking and smok-
ing intensity, the excess risk of death is modeled simply
as the relative risk for current and former smokers not
to increase the model complexity.
Cancer Prevention Study II mortality rates for current,
and never smokers were used since Italian data were
not available. However, these estimates were in agree-
ment with those found in Italian epidemiological studies
for several mortality causes [29].
In modelling relapse rates and relative risks of former
smokers through the two negative-exponential curves,
we used the parameters estimated from cross-sectional
surveys conducted in the Netherlands since figures from
Italy were not available. While relative risks for former
smokers may be assumed to have similar patterns for
the Netherlands and Italy, it is instead uncertain
whether or not relapse in Italy follows the same pattern
observed in the Netherlands.
In comparison with survey estimates of cessation rates,
our model was based on the evolution of tobacco epi-
demic in the Italian population and provided a consis-
tent model of how current and former smokers evolve
over time. Since the knowledge of past time trends in
cessation is necessary to characterize the dynamics of
the tobacco epidemic, and since only few nations collect
data on cessation rates, our model can be used to esti-
mate cessation rates for those countries where this can-
not be estimated from surveys on smoking habits.
Moreover, the model lets to quantify the effects of
smoking interventions on public health, taking into
account the time since cessation of quitters. The latter
is important, since many quitters relapsed and for most
smoking related diseases the increased risks of former
smokers only decreased gradually over time since
cessation.
Conclusions
This model estimated annual cessation probabilities
among Italian smokers in 1986-2009. Results clearly
showed that, over the last 20 years, cessation among Ita-
lian smokers, particularly those aged 30-59 years, was very
low, around 2-5%, and stalled. In order to increase cessa-
tion rates, smoking cessation treatment policies (introdu-
cing total reimbursement of cessation treatments, with a
further development of quitlines and smoking cessation
services) should be empowered and a country-wide mass
media campaign targeting smokers aged 30-59 years and
focusing on promotion of quitting should be implemented.
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